Strategies to Decrease Costs of Prescribing Selective Serotonin Reuptake Inhibitors at a VA Medical Center
Authors:
- Steven K. DobschaSDSteven K. Dobscha
- Thomas A. AndersonTAThomas A. Anderson
- William F. HoffmanWHWilliam F. Hoffman
- Lisa M. WinterbottomLWLisa M. Winterbottom
- Erick H. TurnerETErick H. Turner
- Leann S. SnodgrassLSLeann S. Snodgrass
- Peter HauserPHPeter Hauser
- 1 February 2003
- journal article
- research article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 54 (2) , 195-200
Abstract
The authors examined the efficacy of a multifaceted intervention designed to contain the cost of prescribing selective serotonin reuptake inhibitors (SSRIs) to inpatients and outpatients served by a Veterans Affairs (VA) medical center. Elements of the intervention included identification of a preferred agent, tablet splitting, education and feedback for prescribers, and an electronic record and ordering system to facilitate changes in prescriber behaviors. VA databases were searched for information on use and costs of antidepressants. Over 35 months the number of patients treated with SSRIs and the amount spent on SSRIs increased. However, the mean monthly cost per patient decreased from $57.12 to $42.19. The projected cost savings over the 35 months was approximately $700,000; one-fourth of the savings was due to tablet splitting and three-fourths to changes in the proportions of the various SSRIs prescribed. A survey of the top 75 antidepressant prescribers showed that after the educational interventions, 91 percent were aware that citalopram was the medical center's preferred antidepressant, and 59 percent identified it as their own preferred first-line treatment. The results suggest that multifaceted interventions can influence antidepressant costs through provider education and changes in pharmacy and computerized information processes, resulting in substantial cost savings for institutions.Keywords
This publication has 13 references indexed in Scilit:
- Potential Cost Savings From Pill Splitting of Newer Psychotropic MedicationsPsychiatric Services, 2000
- Kaiser Permanente's Prescription Drug BenefitHealth Affairs, 2000
- Mental Disorders and Mental Health Treatment Among U.S. Department of Veterans Affairs Outpatients: The Veterans Health StudyAmerican Journal of Psychiatry, 1999
- Health-Related Quality of Life in Patients Served by the Department of Veterans AffairsArchives of internal medicine (1960), 1998
- Treatment Costs, Cost Offset, and Cost-Effectiveness of Collaborative Management of DepressionPsychosomatic Medicine, 1998
- Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study1997
- Minimum effective dose for antidepressants - an obligatory requirement for antidepressant drug evaluation?International Clinical Psychopharmacology, 1996
- Pharmacoeconomic Issues in the Treatment of DepressionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1995
- Health Care Costs of Primary Care Patients With Recognized DepressionArchives of General Psychiatry, 1995
- Health care costs associated with depressive and anxiety disorders in primary careAmerican Journal of Psychiatry, 1995